Medincell
Created in 2002
- BETA
Trend leader (A+)
Existing signals make this entity one of the most dynamic startups Social networks
2,243 14,388Activities
Technologies
Entity types
Location
3 Rue des Frères Lumière, 34830 Jacou, France
Jacou
France
Employees
Scale: 51-200
Estimated: 148
SIREN
444606750Engaged corporates
20
4 11Added in Motherbase
3 years, 9 months ago
biotech Value proposition
Better Medicine For All
Better Medicine for All
MedinCell is a pharmaceutical company at commercial stage. We develop a portfolio of long-acting injectables in various therapeutic areas.
Our proprietary technology BEPO® aims to ensure patient compliance, improve the effectiveness and accessibility of treatments, and reduce their environmental footprint.
We collaborate with tier-one pharmaceutical companies and foundations to improve Global Health through new therapeutic options.
Our mission is to contribute to the improvement and protection of the health of populations across the world. The fair sharing of the value created with all our employees is the foundation of our business model. The sustainability of MedinCell is an essential condition for achieving our objectives.
#BetterMedicineForAll #ImpactHealth #GlobalHealth #ControlledRelease #CreativeThinking #InnovationForward #Science
pharmaceutical industry, medical devices, drug delivery, API, joint ventures, R&D, global health, Health innovation, pain control, chronic pain, generic, mental health, compliance, patient safety, controlled release, Polymer chemistry, long acting drug, and patient careOriginal language
Better Medicine For All
Better Medicine for All
MedinCell is a pharmaceutical company at commercial stage. We develop a portfolio of long-acting injectables in various therapeutic areas.
Our proprietary technology BEPO® aims to ensure patient compliance, improve the effectiveness and accessibility of treatments, and reduce their environmental footprint.
We collaborate with tier-one pharmaceutical companies and foundations to improve Global Health through new therapeutic options.
Our mission is to contribute to the improvement and protection of the health of populations across the world. The fair sharing of the value created with all our employees is the foundation of our business model. The sustainability of MedinCell is an essential condition for achieving our objectives.
#BetterMedicineForAll #ImpactHealth #GlobalHealth #ControlledRelease #CreativeThinking #InnovationForward #Science
Home - Medincell
https://www.medincell.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Morgan Stanley Finance, Bank | Morgan Stanley Finance, Bank | Other 6 Sep 2024 | | |
 | IRD | Other 26 Oct 2024 | | |
 AbbVie Pharmaceutical, Pharmaceutical Manufacturing | AbbVie Pharmaceutical, Pharmaceutical Manufacturing | Other 13 Sep 2024 | | |
 Boston Consulting Group (BCG) Consulting, Business Consulting and Services | Boston Consulting Group (BCG) Consulting, Business Consulting and Services | Other 15 Mar 2024 | | |
 Agri Sud-Ouest Innovation Public business cluster, French Cluster, Food and Beverage Manufacturing | Agri Sud-Ouest Innovation Public business cluster, French Cluster, Food and Beverage Manufacturing | Other 5 Nov 2023 | | |
 MSD Pharmaceutical, Pharmaceutical Manufacturing | MSD Pharmaceutical, Pharmaceutical Manufacturing | Other 6 Feb 2020 | | |
 Roland Berger Consulting, Business Consulting and Services | Roland Berger Consulting, Business Consulting and Services | Other 20 Nov 2017 | | |
 Air France Transport, Airlines and Aviation | Air France Transport, Airlines and Aviation | Other 22 Jun 2020 | | |
 Teva Pharmaceuticals Pharmaceutical, Pharmaceutical Manufacturing | Teva Pharmaceuticals Pharmaceutical, Pharmaceutical Manufacturing | Other 23 Sep 2024 | | |
 Montpellier Méditerranée Métropole Environment, Government Administration, French metropolis | Montpellier Méditerranée Métropole Environment, Government Administration, French metropolis | Not capitalistic Not partnership Event 20 Oct 2017 | | |